Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
Condition: Esophageal Squamous Cell Carcinoma Intervention: Drug: Z650 Sponsor: Sunshine Lake Pharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Esophagus Cancer | Genetics | Research | Skin Cancer | Squamous Cell Carcinoma